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Hypoxia regulates RhoA and Wnt/
β-catenin signaling in a context-
dependent way to control re-
differentiation of chondrocytes
Ece Öztürk, Stefanie Hobiger, Evelin Despot-Slade  , Michael Pichler & Marcy Zenobi-Wong  
Cartilage tissue is avascular and hypoxic which regulates chondrocyte phenotype via stabilization 
of HIFs. Here, we investigated the role of hypoxia and HIFs in regulation of Rho and canonical 
Wnt signaling in chondrocytes. Our data demonstrates that hypoxia controls the expression of 
RhoA in chondrocytes in a context-dependent manner on the culturing conditions. Within a 3D 
microenvironment, hypoxia suppresses RhoA on which hypoxia-driven expression of chondrogenic 
markers depends. Conversely, hypoxia leads to upregulation of RhoA in chondrocytes on 2D with a 
failure in re-expression of chondrogenic markers. Similarly to RhoA, hypoxic regulation of Wnt/β-
catenin signaling depends on the microenvironment. Hypoxia downregulates β-catenin within 3D 
hydrogels whereas it causes a potent increase on 2D. Hypoxia-induced suppression of canonical 
Wnt signaling in 3D contributes to the promotion of chondrogenic phenotype as induction of Wnt 
signaling abrogates the hypoxic re-differentiation of chondrocytes. Inhibiting Wnt/β-catenin signaling 
via stabilization of Axin2 leads to a synergistic enhancement of hypoxia-induced expression of 
chondrogenic markers. The effects of hypoxia on Rho and Wnt/β-catenin signaling are HIF-dependent as 
stabilizing HIFs under normoxia revealed similar effects on chondrocytes. The study reveals important 
insights on hypoxic signaling of chondrocytes and how hypoxia regulates cellular mechanisms 
depending on the cellular microenvironment.
Articular cartilage tissue lacks vascularization and has limited access to the body’s healing mechanisms and there-
fore, a low capacity for regeneration once injured or degenerated. Current autologous cell-based cartilage repair 
strategies often involve in vitro monolayer expansion of chondrocytes to achieve sufficient number of cells to be 
implanted1. However, chondrocytes are not phenotypically stable on two-dimensional (2D) culture and lose the 
expression of cartilage-specific markers such as collagen 2 and aggrecan and adopt a fibroblastic phenotype with 
a concomitant upregulation of collagen 12. Development of strategies to overcome such “de-differentiation” and 
induce re-expression of chondrogenic markers in order to ensure regeneration of biochemically and mechan-
ically functional hyaline cartilage tissue still remains a challenge. Methods to biomimic cartilage tissue and 
provide chondrocytes with cues that are present in their native microenvironment include encapsulation in 
three-dimensional (3D) hydrogels, addition of growth factors from the TGF-β, FGF or BMP families and/or 
exposing the chondrocytes to native oxygen levels3–5.
Due to the avascular structure of cartilage tissue, chondrocytes reside in a hypoxic microenvironment with an 
oxygen content ranging from 5–10% O2 in the superficial zone to 1% O2 in the deep zone and adapt metabolically 
to chronic hypoxia6–8. Cultivation of cells under hypoxic conditions has been shown to stimulate re-differentiation 
of chondrocytes9–12 as well as regulate expression of zonal cartilage markers such as superficial zone protein13. 
Furthermore, hypoxia has been reported to promote both Sox-9-mediated chondrogenic differentiation of stem 
cells14, 15 and inhibit chondrocyte hypertrophy16–18. Cells respond to hypoxia through hypoxia-inducible factors 
(HIF), which constitute of a stable β subunit and an oxygen-controlled α subunit. Under normoxic conditions, 
the HIF-α subunit gets hydroxylated via prolyl hydroxylases (PHDs) which targets it to proteosomal degrada-
tion whereas under hypoxia, HIF-α is stabilized, complexes with its β subunit and drives the expression of its 
targets19. All the known HIFs (HIF-1α, 2α and 3α) are shown to be involved in the hypoxia-mediated regulation 
Cartilage Engineering+ Regeneration Laboratory, ETH Zurich, Otto-Stern-Weg 7, 8093, Zurich, Switzerland. 
Correspondence and requests for materials should be addressed to M.Z.-W. (email: marcy.zenobi@hest.ethz.ch)
Received: 26 April 2017
Accepted: 27 July 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCiEntifiC REPoRtS | 7: 9032  | DOI:10.1038/s41598-017-09505-6
of chondrogenic phenotype. HIF-1α has been shown to be a critical survival factor for chondrocytes during 
development20, induce expression of cartilage markers in chondrocytes21, 22 and suppress expression of fibroblastic 
markers23. The role of HIF-2α, on the other hand, has been more controversial where it has been shown to induce 
cartilage matrix production and anabolism24, 25 as well as chondrocyte hypertrophy and catabolism26. Recently, 
HIF-3α has also been attributed a role in the hypoxic-regulation of cartilage markers27.
Besides the involvement and mediation of hypoxic re-differentiation by HIFs, other signaling mechanisms 
that are involved in the maintenance of chondrogenic phenotype under hypoxia remain largely unknown. Here, 
we investigated two signaling pathways known to negatively regulate chondrocyte phenotype, RhoA28 and canon-
ical Wnt signaling29 pathways, in chondrocytes under hypoxic conditions. We hypothesized that hypoxia could 
suppress these signaling pathways in chondrocytes and we explored a possible role of the hypoxic regulation of 
these pathways in the induction of the re-expression of cartilage markers. This study aims at deepening the cur-
rent knowledge on hypoxic signaling mechanisms in chondrocytes that would lead to improvement of cell-based 
cartilage repair strategies.
Results
Hypoxia promotes potent chondrocyte re-differentiation only within a 3D environment and 
in a HIF-dependent manner. Passaged chondrocytes were cultured either in alginate hydrogels (3D) or 
on tissue culture plastic (2D) under normoxic (21% O2) or hypoxic (1% O2) conditions for 7 days. Expression 
of markers of chondrocyte phenotype such as collagen 2 and aggrecan as well as the de-differentiation marker 
collagen 1 were assessed. In 3D hydrogels, collagen 2 (386.3 ± 61.1 fold) and aggrecan (6.1 ± 0.12 fold) gene 
expression showed a potent increase in response to hypoxia whereas collagen 1 expression showed a slight but 
significant decrease (Fig. 1a). On the other hand, when chondrocytes were cultured on 2D, the chondrogenic 
effect of hypoxia decreased drastically and only a minor increase in collagen 2 and aggrecan gene expression 
was observed. Furthermore, expression of collagen 1 mRNA increased significantly on 2D (Fig. 1a). Deposition 
of collagen 2 and collagen 1 was monitored by immunostaining and glycosaminoglycan (GAG) deposition was 
detected by alcian blue staining. In line with the gene expression data, collagen 2 deposition in chondrocytes was 
strongly enhanced by hypoxia in 3D hydrogels (Fig. 1b). Chondrocytes cultured under normoxic conditions were 
observed to deposit high amounts of collagen 1 which was suppressed under hypoxia. Alcian blue staining simi-
larly demonstrated that hypoxic culturing conditions highly promoted GAG deposition in chondrocytes (Fig. 1b). 
On 2D, however, collagen 2 and collagen 1 deposition in chondrocytes cultured under normoxia and hypoxia did 
not show a big difference which correlated with the gene expression data (Figure S1). These results indicate that 
3D culturing and hypoxic microenvironment exert a synergistic effect on the re-expression of cartilage-specific 
markers in passaged chondrocytes.
We next investigated the HIF-dependence of the chondrogenic effect of 3D culturing under hypoxia. For this, 
we treated chondrocytes with deferoxamine (DFO) to stabilize HIFs under normoxic conditions or with YC-1 
to destabilize HIFs under hypoxic conditions. HIF-1α staining revealed protein stabilization only under hypoxia 
and YC-1 treatment led to the degradation of HIF-1α under hypoxic conditions (Figure S2). However, HIF-1α 
staining was unexpectedly only observed to be cytoplasmic under hypoxia which could be due to timing or a 
negative feedback mechanism on the transactivation of the protein (Figure S2). DFO treatment of chondrocytes 
in 3D caused a strong increase in collagen 2 expression (36.4 ± 4.17 fold) under normoxic conditions. Aggrecan 
expression similarly showed a significant increase (2.1 ± 0.26 fold) whereas expression of collagen 1 decreased 
(Fig. 1c). On the other hand, YC-1 treatment under hypoxia suppressed the chondrogenic effect of hypoxia 
on chondrocytes with a drastic loss of collagen 2 expression and a significant decrease in aggrecan expression. 
Interestingly, collagen 1 gene expression also showed a decrease in response to YC-1 treatment in chondrocytes 
(Fig. 1c). Immunofluorescence similarly showed an increase of collagen 2 deposition and a decrease in collagen 1 
in DFO-treated chondrocytes in 3D under normoxia compared to non-treated controls (Fig. 1d). Under hypoxia, 
YC-1 treatment caused a potent loss of collagen 2 as well as GAG deposition of chondrocytes in 3D hydrogels 
(Fig. 1d). On 2D, HIF stabilization under normoxia with DFO treatment caused an increase in collagen 2 gene 
expression even further than hypoxia and collagen 1 expression was suppressed whereas HIF destabilization 
under hypoxia with YC-1 treatment caused a slight decrease in all markers on 2D (Figure S3).
Hypoxia regulates RhoA differently in chondrocytes depending on the culturing condi-
tions. After observing a synergistic effect of hypoxia and 3D culturing on chondrocyte re-differentiation, we 
monitored the expression of cytoskeletal regulator RhoA in chondrocytes under the different oxygen conditions. 
In 3D hydrogels, hypoxia caused a suppression of RhoA protein in chondrocytes. This suppression was found to 
be HIF-dependent as similar downregulation of RhoA was observed under normoxia when the chondrocytes 
were treated with DFO (Fig. 2a,b). RhoA mRNA expression also slightly decreased in response to hypoxia or 
DFO treatment under normoxia in chondrocytes encapsulated in 3D hydrogels (Fig. 2c). Surprisingly, when the 
chondrocytes were cultured on 2D, hypoxia induced a strong increase in RhoA protein levels (Fig. 2d,e). Under 
normoxic conditions, HIF stabilization with DFO treatment caused a similar effect on RhoA protein however the 
increase was less pronounced than hypoxia (Fig. 2d).
Activation of RhoA in 3D hinders the hypoxia-induced re-differentiation of chondrocytes. We 
then investigated the contribution of hypoxia-induced suppression of RhoA in the re-differentiation of chondro-
cytes. We treated chondrocytes with a Rho activator, calpeptin, under hypoxic conditions in 3D and examined 
the expression of chondrogenic markers. Calpeptin treatment led to an upregulation of RhoA protein under 
both hypoxic and normoxic conditions in chondrocytes in 3D (Figure S4a). Furthermore, a strong decrease 
in the hypoxia-induced gene expression of collagen 2 and aggrecan was observed in response to calpeptin in 
3D (Fig. 3a). Similarly, calpeptin treatment hindered the re-differentiation induced by HIF stabilization under 
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Figure 1. Hypoxia induces chondrogenic re-differentiation potently within a 3D context and in a HIF-
dependent manner. (a) mRNA expression of collagen 2, collagen 1 and aggrecan of chondrocytes cultured 
in 3D alginate hydrogels or on 2D under normoxia (21% O2) or hypoxia (1% O2) for 7 days. Mean ± s.d. 
for n = 3; normalized to normoxia; *p < 0.05, ***p < 0.001 when compared to the normoxia sample. 
(b) Immunofluorescence imaging of collagen 2 (green) and collagen 1 (red) and alcian blue staining of 
chondrocytes in 3D alginate hydrogels under normoxia or hypoxia. DAPI (blue) was used for nuclei staining. 
Scale bar: 100 µm. (c) mRNA expression of collagen 2, collagen 1 and aggrecan of chondrocytes in 3D under 
normoxia with DFO (150 µM) treatment or under hypoxia with YC-1 (10 µM) treatment. Mean ± s.d. for 
n = 3; normalized to no treatment; **p < 0.01, ***p < 0.001 when compared to the no treatment sample. 
(d) Immunofluorescence imaging of collagen 2 (green) and collagen 1 (red) and alcian blue staining of 
chondrocytes in 3D under normoxia with DFO (150 µM) treatment or under hypoxia with YC-1 (10 µM) 
treatment. Scale bar: 25 µm.
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normoxic conditions with DFO treatment (Fig. 3b). Moreover, calpeptin caused a slight but significant increase 
in collagen 1 gene expression in DFO-treated chondrocytes (Fig. 3b). Interestingly, on 2D, calpeptin treatment 
under hypoxia or under normoxia in the presence of DFO did not lead to significant changes in the expression 
of chondrogenic markers (Figure S4b). In line with the gene expression results, immunofluorescence and alcian 
blue stainings of chondrocytes in 3D showed that collagen 2 and GAG deposition was suppressed due to calpep-
tin treatment under both hypoxic conditions and under normoxia with DFO treatment (Fig. 3c,d). On the other 
hand, collagen 1 deposition seemed unaffected by calpeptin in chondrocytes in 3D and HIF-stable conditions 
(Fig. 3c,d). These results indicate that hypoxia or hypoxia-mimicking with DFO induce re-differentiation of chon-
drocytes in 3D at least partly via suppression of Rho in a HIF-dependent manner.
Hypoxia causes a HIF-dependent suppression of β-catenin in 3D whereas induces it in 
2D-cultured chondrocytes. We next explored the effect of hypoxia on Wnt/β-catenin signaling in chon-
drocytes under different culturing conditions. Hypoxia induced a potent suppression of β-catenin in chondro-
cytes in 3D hydrogels. Under normoxic conditions with DFO treatment, a similar loss of β-catenin protein levels 
was observed indicating that the effect was HIF-mediated (Fig. 4a). Interestingly, when the chondrocytes were 
cultured on 2D, hypoxia caused a strong increase of β-catenin protein levels in chondrocytes. DFO treatment 
under normoxia, on the other hand, caused a slight upregulation of β-catenin on 2D (Fig. 4a). We then looked 
into the expression of the target genes of Wnt/β-catenin pathway under different oxygen and culturing conditions. 
In line with the β-catenin protein levels, hypoxia or normoxia in the presence of DFO caused a downregulation 
of the target gene cyclin D1 (CCND1) in chondrocytes in 3D hydrogels (Fig. 4b). Similarly, CCND1 gene expres-
sion was upregulated under hypoxia or under normoxia with DFO in chondrocytes cultured on 2D (Fig. 4b). 
Contrarily, another target gene, Axin2, was strongly upregulated under hypoxia in chondrocytes cultured in 3D 
hydrogels, however, no such upregulation was observed in response to DFO treatment under normoxia (Fig. 4c). 
Immunofluorescence for Axin2 protein demonstrated a consistent trend to the gene expression data (Fig. 4d). On 
the other hand, Axin2 gene expression in chondrocytes cultured on 2D did not show a significant difference with 
changing oxygen conditions or HIF stability (Fig. 4c).
Induction of Wnt signaling impedes hypoxia-induced re-differentiation of chondrocytes. In 
order to assess the involvement of β-catenin suppression in induction of chondrogenic re-differentiation under 
hypoxia in 3D, we next investigated the effect of manipulation of Wnt signaling on the expression of cartilage 
markers. First, we cultured chondrocytes in Wnt3a-conditioned medium under hypoxic conditions in 3D 
Figure 2. Hypoxia regulates RhoA differently depending on the culturing conditions in a HIF-mediated 
manner. (a) Western blot showing total RhoA protein in chondrocytes in 3D under hypoxia, normoxia and 
normoxia with DFO (150 µM) treatment. Actin was used as the loading control. (b) Immunofluorescence 
imaging of RhoA (green) and (c) mRNA expression of RhoA in chondrocytes in 3D under hypoxia, normoxia 
and normoxia with DFO (150 µM) treatment. Mean ± s.d. for n = 3; normalized to normoxia; *p < 0.05 
when compared to normoxia. (d) Western blot showing total RhoA protein in chondrocytes on 2D under 
hypoxia, normoxia and normoxia with DFO (150 µM) treatment. Actin was used as the loading control. (e) 
Immunofluorescence imaging of RhoA (green) in chondrocytes on 2D under hypoxia, normoxia and normoxia 
with DFO (150 µM) treatment. Scale bar: 50 µm.
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hydrogels. Upstream induction of Wnt signaling and β-catenin abrogated the hypoxia-mediated re-differentiation 
with a loss of collagen 2 and aggrecan gene expression and no effect on collagen 1 expression (Fig. 5a,b). Collagen 
2 and GAG deposition were also suppressed with Wnt3a treatment (Fig. 5c). Then, we studied the effect of 
inducing canonical Wnt signaling in chondrocytes via inhibition of the β-catenin destruction complex with 
LiCl treatment. LiCl caused a strong increase in β-catenin protein levels in chondrocytes under hypoxic con-
ditions in 3D and a significant decrease in the gene expression of cartilage markers collagen 2 and aggrecan 
(Fig. 5a,b). Hypoxia-induced deposition of collagen 2 and GAGs were also lost in response to LiCl (Fig. 5c). 
LiCl treatment also caused an increase in β-catenin protein in chondrocytes under normoxia in the presence 
of DFO (Figure S5a). Similarly, induction of β-catenin with LiCl dampened the DFO-mediated chondrogenic 
re-differentiation of chondrocytes in 3D (Figure S5b,c). As we found that hypoxia caused a strong increase in 
Axin2 expression, we treated chondrocytes with a stabilizer of Axin2 to investigate its effect on re-differentiation. 
IWR-1 has been identified as an inhibitor of canonical Wnt signaling through stabilizing Axin2 and leading 
to degradation of β-catenin30. IWR-1 treatment of chondrocytes caused a further increase in the gene expres-
sion of collagen 2 and aggrecan under hypoxic conditions whereas collagen 1 expression demonstrated a sig-
nificant decrease (Fig. 5a). However, β-catenin protein levels were unaffected in chondrocytes in response to 
IWR-1 treatment under hypoxia (Fig. 5b). Consistent with the gene expression, IWR-1 treatment reinforced the 
Figure 3. Calpeptin treatment diminishes hypoxia-induced re-differentiation of chondrocytes. (a) mRNA 
expression of collagen 2, collagen 1 and aggrecan of chondrocytes cultured in 3D under hypoxia with or 
without calpeptin (5 μM) treatment. Mean ± s.d. for n = 3; normalized to 3D normoxia control; ***p < 0.001 
when compared to hypoxia. (b) mRNA expression of collagen 2, collagen 1 and aggrecan of chondrocytes 
cultured in 3D under normoxia with DFO (150 μM) or DFO and calpeptin (5 μM) treatment. Mean ± s.d. for 
n = 3; normalized to 3D normoxia control; *p < 0.05, **p < 0.01 when compared to 3D normoxia +DFO. 
(c) Immunofluorescence imaging of collagen 2 (green) and collagen 1 (red) and alcian blue staining of 
chondrocytes in 3D under hypoxia with or without calpeptin (5 μM) treatment. (d) Immunofluorescence 
imaging of collagen 2 (green) and collagen 1 (red) and alcian blue staining of chondrocytes in 3D under 
normoxia with DFO (150 μM) or DFO and calpeptin (5 μM) treatment. Scale bar: 25 µm.
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Figure 4. Hypoxia regulates β-catenin differently depending on the culturing conditions in a HIF-mediated 
manner. (a) Western blot showing β-catenin protein in chondrocytes in 3D and on 2D under hypoxia, normoxia 
and normoxia with DFO (150 µM) treatment. Actin and GAPDH was used as the loading control. (When extra 
lanes in between were removed in the blots, it is indicated with black line separation. Full blots are given in the 
Supplementary Information.) (b) mRNA expression of CCND1 and (c) Axin2 in chondrocytes in 3D or on 2D 
under hypoxia, normoxia and normoxia with DFO (150 µM) treatment. Mean ± s.d. for n = 3; normalized to 
normoxia; *p < 0.05, ***p < 0.001 when compared to normoxia. (d) Immunofluorescence imaging of Axin2 
(green) in chondrocytes in 3D under hypoxia, normoxia and normoxia with DFO (150 µM) treatment. Scale 
bar: 25 µm.
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hypoxia-induced collagen 2 and GAG deposition in chondrocytes (Fig. 5c). These results demonstrate that induc-
tion of Wnt signaling suppresses while inhibition of canonical Wnt signaling enhances the hypoxia-mediated 
re-differentiation of chondrocytes in 3D. Therefore, hypoxia-induced suppression of β-catenin within 3D 
microenvironment contributes to the regulation of chondrocyte phenotype.
Discussion
Autologous cell-based cartilage therapies are challenged by chondrocyte de-differentiation due to monolayer 
expansion which leads to hindered reconstruction of cartilage-specific matrix. Understanding the signaling 
mechanisms that regulate de- and re-differentiation of chondrocytes is crucial to improve the outcome of current 
therapeutic approaches. Hypoxia is a strong inducer of chondrocyte phenotype through stabilization of HIFs, 
however, the hypoxia-induced down-stream signaling pathways that regulate the expression of chondrogenic 
markers are largely unknown. In this work, we demonstrate the hypoxic regulation of Rho and canonical Wnt 
pathways in a context-dependent manner in chondrocytes and their role in the maintenance of chondrogenic 
phenotype.
Our data shows that hypoxia induces chondrocyte re-differentiation in synergy with 3D culturing in line with 
previous reports11, 31. Hypoxic induction of chondrogenic markers is HIF-dependent as hypoxia mimicking via 
stabilization of HIF under normoxic conditions leads to a similar induction of re-differentiation, whereas destabi-
lizing HIF under hypoxia abrogates the expression of chondrogenic markers. HIF-1α has been shown to be a cru-
cial factor in cartilage development that regulates chondrocyte proliferation and cartilage matrix formation20, 32  
as well as during re-differentiation of chondrocytes23. Similarly, HIF-2α has also been reported to mediate 
hypoxic re-differentiation via inducing Sox-9-driven expression of chondrocyte markers24. However, we found 
that hypoxia-induced stabilization of HIFs leads to potent expression of collagen 2 and aggrecan and suppresses 
collagen 1 only in 3D whereas on 2D, chondrogenic markers are mainly unaffected and collagen 1 is significantly 
upregulated. Cellular microenvironment and mechanosensing have been shown to be important factors for sig-
naling of chondrocytes33. 3D culturing induces cell rounding, loss of actin stress fibers and downregulation of 
RhoA in chondrocytes and this loss of RhoA has been found to induce Sox-9-mediated re-differentiation in a 
PKA-dependent manner28. Moreover, RhoA overexpression has been shown to inhibit chondrogenic differenti-
ation of mesenchymal cells34, 35. Therefore, we hypothesized a possible involvement of RhoA in hypoxia-induced 
re-differentiation of chondrocytes. We investigated the effect of hypoxia on the expression of RhoA in 
Figure 5. Induction of Wnt signaling suppresses whereas inhibition enhances hypoxia-induced re-
differentiation of chondrocytes. (a) mRNA expression of collagen 2, collagen 1 and aggrecan of chondrocytes 
cultured in 3D under hypoxia with Wnt3a, LiCl (50 µM) and IWR-1 (5 µM) treatments. Mean ± s.d. for n = 3; 
normalized to 3D hypoxia control; *p < 0.05, **p < 0.01, ***p < 0.001 when compared to hypoxia control. (b) 
Western blots showing β-catenin protein in chondrocytes in 3D under hypoxia with Wnt3a, LiCl and IWR-1 
treatments. Actin was used as the loading control. (c) Immunofluorescence imaging of collagen 2 (green) and 
collagen 1 (red) and alcian blue staining of chondrocytes in 3D under hypoxia with Wnt3a, LiCl and IWR-1 
treatments. Scale bar: 25 µm.
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chondrocytes in 3D and on 2D. In 3D, chondrocytes suppress RhoA expression on both gene and protein levels 
in response to hypoxia in a HIF-mediated manner whereas on 2D hypoxia promotes RhoA. Hypoxia-induced 
effects on RhoA have only been addressed in a few studies in literature and they exclusively reported a positive 
regulation of RhoA. Hypoxia-triggered activation of RhoA signaling was shown to induce focal adhesions and 
motility in breast cancer cells36. Another study demonstrated upregulation of RhoA under low oxygen condi-
tions in cardiac myocytes leading to increased calcium channels and ischemic arrhythmias37. Similar induction 
of RhoA by hypoxia was shown to be involved in cell spreading38, migration of mesenchymal cells39, protection 
of neuroblastoma cells from apoptosis40 and morphogenic branching of lung explants41. Here, we show for the 
first time that hypoxia can both induce and suppress RhoA signaling in chondrocytes depending on the cellular 
microenvironment. Furthermore, we found that the hypoxic inhibition of RhoA is involved in the re-expression 
of chondrogenic markers in 3D under hypoxia.
RhoA signaling has been shown to have a crosstalk with Wnt signaling to regulate a variety of cellular pro-
cesses such as cell motility and differentiation42, 43. Induction of Wnt/β-catenin signaling via activation of RhoA 
has been reported to induce osteogenic differentiation of mesenchymal cells with increased transcriptional activ-
ity of β-catenin43. Furthermore, Wnt/β-catenin signaling is known to be a negative regulator of chondrocyte 
phenotype and chondrogenic differentiation through inhibition of Sox-9-mediated transctiption29, 44, 45. Hence, 
we also investigated the hypoxic regulation of Wnt/β-catenin pathway in chondrocytes. Similar to the regulation 
of RhoA, our data show that hypoxia has differential effects on the expression of β-catenin in chondrocytes. When 
the cells are cultured on 2D, hypoxia induces β-catenin whereas suppresses it in 3D in a HIF-dependent man-
ner. Hypoxia has been shown to induce β-catenin activation and downstream signaling in stem cells46. Another 
study reported induction of Wnt11 in response to hypoxia to promote cellular proliferation and migration47. 
Moreover, β-catenin and HIF-1α interaction has been shown to regulate adaptation of tumor cells to hypoxia 
and drive HIF-mediated transcription48. On the other hand, HIF-1α-induced inhibition of Wnt signaling has 
also been reported in osteoblasts to control cell proliferation49. Interaction of HIF-1α and β-catenin was shown 
to suppress expression of matrix metalloprotease 13 (MMP13) and inhibit chondrocyte catabolism50. Our results 
show that hypoxia suppresses β-catenin signaling in chondrocytes in 3D which positively regulates expression of 
chondrogenic markers. Induction of canonical signaling in chondrocytes with Wnt-3a or LiCl treatment abro-
gates the hypoxia-induced re-differentiation of chondrocytes in 3D. Interestingly, when β-catenin is inhibited, 
Axin2, a known target of the β-catenin transcriptional activity, is potently expressed under hypoxic conditions 
in 3D whereas CCND1, another β-catenin target, is suppressed. Axin2 has been previously shown to regulate 
chondrocyte phenotype, enhance TGF-β signaling, promote collagen 2 expression and inhibit chondrocyte 
hypertrophy51, 52. Our data similarly demonstrate that an upregulation of Axin2 gene and protein expression 
under hypoxia accompanies chondrocyte re-differentiation and positively regulates chondrogenic phenotype in 
3D. Furthermore, Axin2 stabilization with IWR-1 treatment exerts a synergistic effect with hypoxia on the expres-
sion of chondrogenic markers and promotes chondrocyte re-differentiation even on 2D (Fig. S6).
In summary, this study shows the role of suppression of Rho and canonical Wnt signaling in the re-expression 
of chondrocyte phenotype under hypoxic conditions in 3D. These results contribute to the understanding of 
hypoxic regulation of signaling events in chondrocytes and development of new strategies for cell-based 
approaches in cartilage repair. Although we used severe hypoxia (1% O2) to mimic the oxygen tension in the deep 
zone chondrocytes, it would be of great interest to investigate whether similar effects would be observed within a 
range of hypoxic conditions. Moreover, this is the first demonstration of context-dependent regulation of RhoA 
and β-catenin in response to hypoxia and HIF stabilization (Fig. 6). Our results emphasize the importance of 
taking the cellular microenvironment and 3D context into consideration when studying regulation of signaling 
Figure 6. Scheme showing hypoxia-controlled expression of RhoA and β-catenin in chondrocytes. On 2D, 
hypoxia and HIF stabilization lead to an induction of RhoA and Wnt/β-catenin signaling in chondrocytes 
that leads to hindered re-differentiation and upregulation of collagen1. However, when chondrocytes are 
encapsulated in 3D hydrogels, RhoA and β-catenin are suppressed in response to hypoxia in a HIF-dependent 
manner with potent re-differentiation of chondrocytes marked by upregulation of collagen 2 and aggrecan.
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pathways under hypoxia. Therefore, the implications of this study are not limited to chondrocyte signaling but 
include other cellular phenomena where hypoxic signaling plays a crucial role such as stem cell differentiation 
and cancer.
Materials and Methods
Chondrocyte isolation and culture. Articular cartilage was removed from the knee joint of cows (1–2 
years old, n = 3) with a sterile blade and minced. Cartilage pieces were washed with DMEM (Glutamax, high 
glucose) (Life Technologies) supplemented with 1% penicillin-streptomycin (P/S) (Gibco) and digested with 0.1% 
collagenase (Sigma) in DMEM supplemented with 5% fetal bovine serum (FBS) (Life Technologies) for 5 h at 
37 °C with gentle shaking. Digested tissue was filtered with a 100 µm and then a 40 µm cell strainer followed by 
centrifugation at 500 g for 10 min and washed twice with culture medium (DMEM supplemented with 10% FBS 
and 50 µg/mL L-Ascorbic acid -2-phosphate (Sigma)). Chondrocytes were seeded in culture medium at a density 
of 5,000 cells/cm2 and medium was changed every 2–3 days. Cells were passaged at 80–90% confluence up to 
passage three.
Re-differentiation of chondrocytes. At passage 3, the chondrocytes were either seeded onto tissue cul-
ture plastic (2D) or encapsulated into alginate hydrogels (3D). For 2D cultures, chondrocytes were seeded in 
culture medium at a density of 5,000 cells/cm2. For 3D encapsulation, chondrocyte suspension was mixed with 
sterile-filtered alginate (Novamatrix) solution in 150 mM NaCl at a final polymer concentration of 1% (w/v) and 
cell density of 6 × 106 cells/mL. 30 µl discs of the mixture were pipetted onto gel casters and gelled in a 100 mM 
CaCl2 bath for 10 min. Chondrocytes on 2D or in alginate gels were cultured for in control medium or culture 
medium with the indicated drug treatments and cultured for 7 days under normoxic (21% O2) or hypoxic (1% 
O2) conditions.
Drugs treatments used for the re-differentiation experiments. Chondrocyte culture medium was 
supplemented with the following drugs at the indicated concentrations: deferoxamine (DFO) (150 μM), YC-1 
(10 μM), calpeptin (5 μM), lithium chloride (50 μM), IWR-1 (5 μM). All the drugs were purchased from Sigma. 
Wnt-3a-conditioned medium was produced as previously reported53 and used by mixing 1:1 with chondrocyte 
culture medium.
Western blotting. For 2D samples, RIPA buffer with protease inhibitors (Sigma) was pipetted onto the cell 
monolayer, incubated on ice for 15 min and the lysate was removed with a scraper. For 3D samples, alginate 
gels were washed twice with 150 mM NaCl/5 mM CaCl2 and stored at −80 °C. Then, the frozen hydrogels were 
homogenized with an electrical pestle in RIPA buffer with protease inhibitors and incubated on ice for 30 min-
utes. Both 2D and 3D samples were then centrifuged at 10′000 g for 15 min, the supernatant was collected and 
the protein concentration was determined by Bradford assay (Bio-Rad). The samples were diluted with Laemmli 
buffer and RIPA and were kept at 95 °C for 5 min. 10–15 µg protein was loaded in pre-casted 4–12% Bis-Tris gels 
(Life Technologies) and run for 35 min at 125 V followed by transferring onto a nitrocellulose membrane for 1 h 
at 25 V. The membrane was washed twice with ddH2O, stained with Ponceau S (Sigma) for protein visualization 
and washed three times with tris-buffered saline with tween-20 (TBST) buffer. The membrane was blocked with 
5% BSA for 1 h at RT and incubated with primary antibody overnight at 4 °C. The membrane was then washed 
four times with TBST for 8 minutes and incubated with the secondary antibody for 1 h at RT, washed again and 
visualized with Clarity Western ECL Substrate (Bio-Rad) for chemiluminescence. The primary antibodies used 
were anti-β-catenin (Abcam, ab32572; 1:1000), anti-RhoA (Santa Cruz, SC-418; 1:200), anti-actin (Sigma, A2066; 
1:1000) and anti-GAPDH (Cell Signaling, 2118 S; 1:1000). The secondary antibodies used were anti-rabbit-HRP 
(Cell Signaling, 7074; 1:1000) and anti-mouse-HRP (Cell Signaling, 7076; 1:1000).
Real-time quantitative PCR. For the 2D samples, lysis buffer (Macherey-Nagel AG) was added 
on the cells; the lysate was removed with a scraper and collected. For the 3D samples, alginate gels were 
collected, frozen and homogenized with an electrical pestle in lysis buffer. RNA was isolated with the 
NucleoSpin miRNA kit (Macherey-Nagel AG) according to the manufacturer’s instructions. RNA concen-
tration was determined with a plate reader (Tek3 plate, Synergy, BioTek, Inc.). RNA was reverse transcribed 
and cDNA was amplified by quantitative real-time PCR (StepOnePlus, Applied Biosystems). Ribosomal pro-
tein L13 (RPL13a) was used as endogenous reference gene and fold change was quantified with the ΔΔCt 
method. The following primers for bovine (Microsynth AG) were used in this study: RPL13a (forward (F) 
5′-GCCAAGATCCACTATCGGAAA-3′; reverse (R) 5′-AGGACCTCTGTGAATTTGCC-3′), COL2A1 
(Collagen 2) (F, 5′-GGCCAGCGTCCCCAAGAA-3′; R, 5′-AGCAGGCGCAGGAAGGTCAT-3′), ACAN 
(aggrecan) (F, 5′-GGGAGGAGACGACTGCAATC-3′; R, 5′-CCCATTCCGTCTTGTTTTCTG-3′), COL1A2 
(Collagen 1) (F, 5′-CGAGGGCAACAGCAGATTCACTTA-3′; R, 5′-GCAGGCGAGATGGCTTGTTTG-3′), 
RHOA (F, 5′-TGTATGTCCCTACGGTGTTTG-3′; R, 5′-CGATCATAATCTTCCTCGCCAG-3′), CCND1 
(cyclin D1) (F, 5′-TTACACTGACAACTCCATCCG-3′; R, 5′-CATCTTGGAGAGGAAGTGCTC-3′), Axin2 (F, 
5′-GAACCTGAAGGATCGCAAAA-3′; R, 5′-GGTTTCAGCTGCTTGGAGAC-3′).
Immunohistochemisty. For the 2D samples, the cells were washed with PBS and fixed with 4% formalde-
hyde with 0.1% Triton-X in PBS for 20 min at 4 °C. The samples were washed again twice with PBS and blocked 
1 h with 5% BSA at RT followed by incubation with primary antibody overnight at 4 °C. Next, the samples were 
washed with PBS, incubated with secondary antibody for 1 h at RT, washed again with PBS, stained with DAPI 
and phalloidin-rhodamine for 15 min and imaged with fluorescence microscopy. For the 3D samples, alginate 
gels were fixed with 4% formaldehyde (Sigma) with 0.1% Triton-X (Sigma) in PBS for 1 h at 4 °C and washed 
twice with 150 mM NaCl/5 mM CaCl2. Then, the gels were kept in a 1:1 mixture of PBS and optimum cutting 
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temperature compound (OCT, VWR) for 2 h at RT and then embedded in OCT overnight. The samples were 
frozen on dry ice and cut with a cryotome (CryoStar NX70, ThermoScientific) into 5 µm sections. The sections 
were washed with PBS and blocked with 5% BSA for 1 h at RT followed by incubation with primary antibody in 
1% BSA overnight at 4 °C. Next, the sections were washed in PBS, incubated with the secondary antibody in 1% 
BSA for 1 h at RT, washed again and stained with DAPI for 15 min at RT. Then, the sections were mounted with 
aqueous mounting media (Vector Laboratories) and imaged with fluorescence microscopy. The primary anti-
bodies used were anti-Collagen 2 (II-II6B3, DSHB, 1:20), anti-Collagen 1 (Abcam, ab6308, 1:200), anti-RhoA 
(Santa Cruz, SC-418; 1:200) and anti-Axin2 (Sigma, SAB3500619; 1:200). The secondary antibodies used were 
AlexaFluor 488 goat anti-mouse IgG and goat anti-rabbit IgG (Life Technologies, A10680, A11008, 1:300).
Alcian blue staining. Both 2D samples and sections of 3D samples were washed with ddH2O and incubated 
with 3% acetic acid (Sigma) for 10 minutes. Then, the samples were incubated with alcian blue solution (Sigma) 
for 20 minutes, washed with ddH2O followed by imaging with light microscopy.
Statistical analysis. Quantitative data are represented as mean ± standard deviation (s.d.) and obtained 
from three independent experiments. Analysis of variance (ANOVA) with Tukey’s and Bonferonni’s post-hoc 
tests were performed for statistical analyses and p values less than 0.05 were considered as statistically significant.
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